XSU-T -0.22 SOLQ-T -0.79 SVR-T 0.36 MAL-T 0.28 CHTR-Q 1.95 IDT-N -0.7 FI-N 0.53
Daily Stock Opinions and Ratings
Stockchase Opinions

Robert Floyd PanGeo Pharma PIL.H-X TOP PICK Dec 18, 2002

(Was a top pick on Nov 1. Down 6%) Made a good acquisition. Earnings are strong. Very cheap.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$2.080

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

BUY

PanGeo Pharma(PIL.H-X)

Mar 27, 2003
Earnings warnings were forcast. Seems to be corrected now. Cheap.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$0.730

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Mar 31, 2003
Likes this sector, but they just gave a lower guidance.
John Sinkins, CFAJohn Sinkins, CFA
Unknown
Unlock Rating
$0.690

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

PanGeo Pharma(PIL.H-X)

Apr 10, 2003
Has warned a few times. Making some strategic moves in beefing up their management. A reasonable bet.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$0.770

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Apr 25, 2003
Made a good move in splitting the offices of the chairman and the CEO. They are trying to deal with their problems. Have to see an improvement before there is any interest.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$0.760

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

May 06, 2003
Have had some pretty big earnings misses and management issues. May be a take over target at some point. Wait for it to drop further.
Peter HodsonPeter Hodson
Unknown
Unlock Rating
$0.960

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

May 30, 2003
Very extended. Squeezing their credit lines and suppliers. Have to earn $0.10 a share to support the liquidity issue.
Lou SchizasLou Schizas
Unknown
Unlock Rating
$0.740

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Jul 02, 2003
In a very defined downtrend.
Bill CarriganBill Carrigan
No
Unlock Rating
$0.290

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Jul 04, 2003
Auditors left and have to be replaced and trading has been stopped until their reports are in.
Robert FloydRobert Floyd
Owned
Unlock Rating
$0.290

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Jul 22, 2003
Doesn't look good.
David BurrowsDavid Burrows
No
Unlock Rating
$0.290

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Sep 22, 2003
Trading has been stopped. Plagued by a number of problems. Waiting for the company to complete its audit.
Robert FloydRobert Floyd
Owned
Unlock Rating
$0.290

Stock price when the opinion was issued

biotechnology pharmaceutical

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

VHI-T -0.15$12.6
AFRM-Q 8.47$88.46
XID-T -0.62$53.17
EMMF-N 0$
UMAX-T -0.13$13.59

Today's Top Picks

XSU-T -0.22$44.85
SOLQ-T -0.79$22.05
SVR-T 0.36$18.91
MAL-T 0.28$15.94
CHTR-Q 1.95$265.58

Popular Articles

Latest Sell Signals

HMAX-T 0.055$14.99
WSM-N 0.13$188.19
CSU-T 128.41$4550.34
COST-Q -1.64$943.32
FICO-N 15.27$1521.64

Most Recent Experts

Mike Philbrick

Mike Philbrick

ReSolve Asset Management

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica